Same Exposure but two radically different responses to antibiotics: Resilience of the salivary microbiome versus long-term microbial shifts in feces

mBio

Volumn 6, Issue 6, 2015, Pages

  Zaura, Egija ^a   Brandt, Bernd W ^a   de Mattos, M Joost Teixeira ^b   Buijs, Mark J ^a   Caspers, Martien P M ^c   Rashid, Mamun Ur ^d   Weintraub, Andrej ^d   Nord, Carl Erik ^d   Savell, Ann ^e   Hu, Yanmin ^e   Coates, Antony R ^e   Hubank, Mike ^f   Spratt, David A ^g   Wilson, Michael ^g   Keijser, Bart J F ^c   Crielaard, Wim ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c TNO   (Netherlands)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e c o Earlsfield Business Centre   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; MINOCYCLINE; PLACEBO; RNA 16S; ANTIINFECTIVE AGENT; RIBOSOME DNA;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; FECES MICROFLORA; FEMALE; HUMAN; MALE; METAGENOMICS; MOUTH FLORA; MULTICENTER STUDY (TOPIC); NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); YOUNG ADULT; CHEMISTRY; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFECTS; FECES; GENETICS; MICROBIOLOGY; MICROFLORA; RANDOMIZED CONTROLLED TRIAL; SALIVA; SWEDEN; TIME FACTOR; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; DNA, RIBOSOMAL; FECES; HEALTHY VOLUNTEERS; HUMANS; MICROBIOTA; PLACEBOS; RNA, RIBOSOMAL, 16S; SALIVA; SEQUENCE ANALYSIS, DNA; SWEDEN; TIME FACTORS; UNITED KINGDOM;

EID: 84952802604     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01693-15     Document Type: Article

References (43)

1. Cantas L, Shah SQA, Cavaco LM, Manaia CM, Walsh F, Popowska M, Garelick H, Bürgmann H, Sørum H. 2013. A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota. Front Microbiol 4:96. http://dx.doi.org/ 10.3389/fmicb.2013.00096.
2. Alanis AJ. 2005. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 36:697-705. http://dx.doi. org/1 0. 1 0 1 6 / j.arcmed.2005.06.009.
3. Clemente J, Ursell L, Parfrey L, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148:1258-1270. http://dx.doi.org/10.1016/j.cell.2012.01.035.
4. Modi SR, Collins JJ, Relman DA. 2014. Antibiotics and the gut microbiota. J Clin Invest 124:4212-4218. http://dx.doi.org/10.1172/JCI72333.
5. Munyaka PM, Khafipour E, Ghia J. 2014. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front Pediatr 2:109. http://dx.doi.org/10.3389/fped.2014.00109.
6. Roberts SE, Wotton CJ, Williams JG, Griffith M, Goldacre MJ. 2011. Perinatal and early life risk factors for inflammatory bowel disease. World J Gastroenterol 17:743-749. http://dx.doi.org/10.3748/wjg.v17.i6.743.
7. Ferreira CM, Vieira AT, Vinolo MAR, Oliveira FA, Curi R, Martins FDS. 2014. The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res 2014:689492. http://dx.doi.org/10.1155/2014/ 689492.
8. Willing BP, Russell SL, Finlay BB. 2011. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 9:233-243. http://dx.doi.org/10.1038/nrmicro2536.
9. Abdulah R. 2012. Antibiotic abuse in developing countries. Pharm Regul Aff 1:e106. http://dx.doi.org/10.4172/2167-7689.1000e106.
10. Widayati A, Suryawati S, de Crespigny C, Hiller JE. 2011. Self medication with antibiotics in Yogyakarta City Indonesia: a cross sectional population-based survey. BMC Res Notes 4:491. http://dx.doi.org/ 10.1186/1756-0500-4-491.
11. ESPAUR Writing Committee. 2014. English surveillance programme for antimicrobial utilization and resistance (ESPAUR). Report 2014. Public Health England, London, United Kingdom. https://www.gov.uk/ government/publications/english-surveillance-programmeantimicrobial-utilisation-and-resistance-espaur-report.
12. European Centre for Disease Prevention and Control. 2014. Surveillance of antimicrobial consumption in Europe 2012. ECDC, European Centre for Disease Prevention and Control, Stockholm, Sweden.
13. Fernandez y Mostajo M, Zaura E, Crielaard W, Beertsen W. 2011. Does routine analysis of subgingival microbiota in periodontitis contribute to patient benefit? Eur J Oral Sci 119:259-264. http://dx.doi.org/10.1111/ j.1600-0722.2011.00828.x.
14. Keenan JR, Veitz-Keenan A. 2015. Antibiotic prophylaxis for dental implant placement? Evid Based Dent 16:52-53. http://dx.doi.org/10.1038/ sj.ebd.6401097.
15. Oomens MAE, Forouzanfar T. 2012. Antibiotic prophylaxis in third molar surgery: a review. Oral Surg Oral Med Oral Pathol Oral Radiol 114:e5-e12. http://dx.doi.org/10.1016/j.oooo.2011.10.023.
16. Dethlefsen L, Huse S, Sogin ML, Relman DA. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280. http://dx.doi.org/10.1371/ journal.pbio.0060280.
17. Dethlefsen L, Relman DA. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108:4554-4561. http://dx.doi.org/ 10.1073/pnas.1000087107.
18. Rashid M, Zaura E, Buijs MJ, Keijser BJF, Crielaard W, Nord CE, Weintraub A. 2015. Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods. Clin Infect Dis 60:S77-S84. http:// dx.doi.org/10.1093/cid/civ137.
19. Canu A, Leclercq R. 2009. Macrolides and lincosamides, p 211-221. In Mayers DL (ed), Antimicrobial drug resistance, vol 1. Mechanisms of drug resistance. Humana Press, Springer, New York, NY.
20. Guay D. 2007. Update on clindamycin in the management of bacterial, fungal and protozoal infections. Expert Opin Pharmacother 8:2401-2444. http://dx.doi.org/10.1517/14656566.8.14.2401.
21. Moudgal VV, Kaatz GW. 2009. Fluoroquinolone resistance in bacteria, p 195-205. In Mayers DL (ed), Antimicrobial drug resistance, vol 1. Mechanisms of drug resistance. Humana Press, Springer, New York, NY.
22. Rang HP, Dale MM. 1991. Pharmacology, 2nd ed, p 804-832. Churchill Livingstone, London, United Kingdom.
23. Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C. 2013. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31: 814-821. http://dx.doi.org/10.1038/nbt.2676.
24. Liu B, PopM. 2009. ARDB-antibiotic resistance genes database. Nucleic Acids Res 37:D443-D447. http://dx.doi.org/10.1093/nar/gkn656.
25. Vital M, Howe AC, Tiedje JM. 2014. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. mBio 5:e00889-14. http://dx.doi.org/10.1128/mBio.00889-14.
26. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer R-. 2008. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27:104-119. http://dx.doi.org/10.1111/j.1365-2036.2007.03562.x.
27. Albenberg LG, Wu GD. 2014. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 146:1564-1572. http://dx.doi.org/10.1053/j.gastro.2014.01.058.
28. Mager DL, Ximenez-Fyvie LA, Haffajee AD, Socransky SS. 2003. Distribution of selected bacterial species on intraoral surfaces. J Clin Periodontol 30:644-6 5 4. http://dx.doi. org/1 0. 1 0 3 4 / j. 1 6 0 0-051X.2003.00376.x.
29. Li K, Bihan M, Methé BA. 2013. Analyses of the stability and core taxonomic memberships of the human microbiome. PLoS One 8:e63139. http://dx.doi.org/10.1371/journal.pone.0063139.
30. Sommer MOA, Dantas G, Church GM. 2009. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325:1128-1131. http://dx.doi.org/10.1126/science.1176950.
31. Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O. 2008. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8:125-132. http:// dx.doi.org/10.1016/S1473-3099(08)70017-3.
32. Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. 2001. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 67:561-568. http://dx.doi.org/10.1128/AEM.67.2.561-568.2001.
33. Ochman H, Lawrence JG, Groisman EA. 2000. Lateral gene transfer and the nature of bacterial innovation. Nature 405:299-304. http:// dx.doi.org/10.1038/35012500.
34. Marsh PD, Moter A, Devine DA. 2011. Dental plaque biofilms: communities, conflict and control. Periodontol 2000 55:16-35. http://dx.doi.org/ 10.1111/j.1600-0757.2009.00339.x.
35. Abeles SR, Ly M, Santiago-Rodriguez TM, Pride DT. 2015. Effects of long term antibiotic therapy on human oral and fecal viromes. PLoS One 10:e0134941. http://dx.doi.org/10.1371/journal.pone.0134941.
36. Zaura E, Keijser BJ, Huse SM, Crielaard W. 2009. Defining the healthy "core microbiome" of oral microbial communities.BMCMicrobiol 9:259. http://dx.doi.org/10.1186/1471-2180-9-259.
37. Kraneveld EA, Buijs MJ, Bonder MJ, Visser M, Keijser BJF, Crielaard W, Zaura E. 2012. The relation between oral Candida load and bacterial microbiome profiles in Dutch older adults. PLoS One 7:e42770. http:// dx.doi.org/10.1371/journal.pone.0042770.
38. Koopman JE, Röling WFM, Buijs MJ, Sissons CH, ten Cate JM, Keijser BJF, Crielaard W, Zaura E. 2015. Stability and resilience of oral microcosms toward acidification and Candida outgrowth by arginine supple-mentation. Microb Ecol 69:422-433. http://dx.doi.org/10.1007/s00248-014-0535-x.
39. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114-2120. http:// dx.doi.org/10.1093/bioinformatics/btu170.
40. Edgar RC. 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26:2460-2461. http://dx.doi.org/10.1093/ bioinformatics/btq461.
41. Abubucker S, Segata N, Goll J, Schubert AM, Izard J, Cantarel BL, Rodriguez-Mueller B, Zucker J, Thiagarajan M, Henrissat B, White O, Kelley ST, Methé B, Schloss PD, Gevers D, Mitreva M, Huttenhower C. 2012. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol 8:e1002358. http:// dx.doi.org/10.1371/journal.pcbi.1002358.
42. Hammer O, Harper DAT, Ryan PD. 2001. PAST: paleontological statistics software package for education and data analysis. Palaeontol Electron 4:1-9.
43. Parks DH, Tyson GW, Hugenholtz P, Beiko RG. 2014. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30: 3123-3124. http://dx.doi.org/10.1093/bioinformatics/btu494.